ASBM Presents to New York State Pharmacy Society 

On June 3rd, ASBM’s Advisory Board Chair Dr. Philip Schneider, Associate Dean at the University of Arizona’s College of Pharmacy, presented to the Pharmacy Society of the State of New York (PSSNY) at a forum held at the Albany College of Pharmacy.

Dr. Schneider discussed how biologics and chemical drugs differ in terms of size, complexity, and sensitivity and how biosimilars differ from generic versions of chemical drugs.

He also explained how policymakers are addressing these differences in regards to biosimilar naming, labeling and substitution policy and presented the perspectives of healthcare providers on these issues, with data drawn from ASBM’s surveys of US physicians and pharmacists and Continuing Education courses